Samuel Matan Silverman, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 2110 Washington Blvd, Arlington, VA 22204 Phone: 703-228-6040 |
Michele Halberda, OTR/L Occupational Therapist - Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 625 S Wakefield St, Arlington, VA 22204 Phone: 412-654-6426 |
Leah Mckelvey, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 3821 Wilson Blvd, Arlington, VA 22203 Phone: 703-214-8064 |
Sarah Katherine Sowd, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 1785 S Hayes St, Arlington, VA 22202 Phone: 703-685-3000 |
Jennifer G Rosenberg, OTR/L Occupational Therapist - Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 705 N Nelson St, Arlington, VA 22203 Phone: 703-819-8225 |
Katie Yates, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 1785 S Hayes St, Arlington, VA 22202 Phone: 703-920-5700 |
Erin Elizabeth Kelly, OTR/L Occupational Therapist Medicare: Medicare Enrolled Practice Location: 2301 Columbia Pike Apt 125, Arlington, VA 22204 Phone: 571-527-0818 |
Kristin Marie Wallace, OTR/L Occupational Therapist - Human Factors Medicare: Not Enrolled in Medicare Practice Location: 2110 Washington Blvd Ste. 158, Arlington, VA 22204 Phone: 202-427-8290 |
Ms. Laura Bell Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 2301 Columbia Pike Apt 125, Arlington, VA 22204 Phone: 202-544-5439 |
Miss Kahkashan Neseem, BS Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 3800 Fairfax Dr, Appartment#306, Arlington, VA 22203 Phone: 703-243-9343 |
Rosa May Dais Occupational Therapist Medicare: Medicare Enrolled Practice Location: 1785 S Hayes St, Arlington, VA 22202 Phone: 703-920-5700 |
Stephanie Kristin Ziola Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 2301 Columbia Pike, Suite 125, Arlington, VA 22204 Phone: 202-544-5439 |
Sonali Kanitkar, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 2445 Army Navy Dr Ste 305, Arlington, VA 22206 Phone: 703-813-6330 Fax: 301-710-6379 |
Erin Conly Occupational Therapist Medicare: Accepting Medicare Assignments Practice Location: 900 N Taylor St, Arlington, VA 22203 Phone: 703-516-5455 |
Lilyan Williams Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 2110 Washington Blvd, Arlington, VA 22204 Phone: 703-228-6040 |
Christine Laporte Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 2776 S Arlington Mill Dr # 534, Arlington, VA 22206 Phone: 703-879-2479 Fax: 703-879-2803 |
Mckayla Renee Boll, OTR/L Occupational Therapist Medicare: Medicare Enrolled Practice Location: 1330 S Fair St Apt 412, Arlington, VA 22202 Phone: 716-790-1069 |
Xiaoxue Zhang, OT Occupational Therapist Medicare: Medicare Enrolled Practice Location: 2800 S Shirlington Rd Ste 1100, Arlington, VA 22206 Phone: 703-892-6500 Fax: 703-521-3415 |
Mr. Jonathan Cheung, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 1701 N George Mason Dr, Arlington, VA 22205 Phone: 703-558-6507 |
Sharon Goodwin, MS, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 2301 Columbia Pike Apt 125, Arlington, VA 22204 Phone: 206-251-6075 |
News Archive
HUYA Bioscience International, a leader in globalizing China's biopharmaceutical innovation, today announced a strategic partnership with the School of Chinese Materia Medica of the Beijing University of Chinese Medicine (BUCM). As one of a series of collaborations that HUYA has established with China's leading research and development institutions, the agreement demonstrates HUYA's visionary commitment to enabling and accelerating the global development and commercialization of novel biopharmaceutical products originating in China.
Forbion Capital Partners, a leading investment firm dedicated to the life science sector, today announces the final closings of both FCF I Co-Invest Fund and of FCF II, raising a total of more than €190m ($240m). Forbion's €54m Co-Invest Fund aims to invest alongside FCF I in a select number of late-stage FCF I portfolio companies.
Restricting use of drugs for macular degeneration to patients who have already gone blind in one eye is "unacceptable" concludes the July issue of Drug and Therapeutics Bulletin (DTB).
Everist Genomics, a prognostics company focused on developing gene-based molecular assays for the prediction of cancer recurrence, today announced the positive results of the first external validation study of its OncoDefender-CRC colorectal cancer recurrence test. The study is being conducted by Mayo Validation Support Services, and is being coordinated with investigators and resources from all three Mayo Clinic sites.
› Verified 5 days ago